Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Miguel Angel Lopez Nevot"'
Autor:
Steven G.E. Marsh, Miguel Angel Lopez Nevot, Francisco Ruiz-Cabello, Isabel Maleno, Laura Paco, Teresa Rodríguez, Graham Pawelec, Rosa Mendez, Chrissy h. Roberts, Federico Garrido, I. Anthony Dodi
Publikováno v:
Cancer Immunology, Immunotherapy. 54:141-148
Malignant transformation of cells is frequently associated with abnormalities in human leukocyte antigen (HLA) expression. MHC class I loss or down-regulation in cancer cells is a major immune escape route used by a large variety of human tumours to
Autor:
Natalia, Aptsiauri, Teresa, Cabrera, Angel, Garcia-Lora, Miguel Angel, Lopez-Nevot, Francisco, Ruiz-Cabello, Federico, Garrido
Publikováno v:
International review of cytology. 256
MHC class I antigens play a crucial role in the interaction of tumor cells with the host immune system, in particular, in the presentation of peptides as tumor-associated antigens to cytotoxic lymphocytes (CTLs) and in the regulation of cytolytic act
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Teresa Cabrera, Federico Garrido, Miguel Angel Lopez Nevot, Francisco Ruiz-Cabello, Javier Esquivias, Javier Gutierrez
Publikováno v:
Immunobiology. 180(2-3)
Class II HLA antigen expression was studied in 30 polyps from 3 patients who were diagnosed with familial polyposis coli. The highest levels of this expression were associated with the most severe grades of dysplasia (p less than 0.00001), the sequen
Autor:
Francisco Ruiz-Cabello, Federico Garrido, Miguel Angel Lopez Nevot, Susana Pedrinaci, C. Huelin
Publikováno v:
Hybridoma. 8:1-11
Different monoclonal antibodies detecting the leucocyte common antigen have been obtained, for CD45 (GRT2, GRT3 and GRT4) and for CD45R (GRT22). Several epitopes have been defined with these monoclonal antibodies (MAbs). We have performed a comparati
Publikováno v:
International Journal of Cancer; 4/20/2004, Vol. 109 Issue 4, p636-638, 3p
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781489950390
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ba94d5941dc2d10f28df81a5eb726ef
https://doi.org/10.1007/978-1-4899-5037-6_14
https://doi.org/10.1007/978-1-4899-5037-6_14
Autor:
Rueda B, Miguel Angel Lopez Nevot, Mj, Lopez-Diaz, Garcia-Porrua C, Martín J, Ma, Gonzalez-Gay
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::441d0fc6b43773999697b6b46b6815a1
http://www.scopus.com/inward/record.url?eid=2-s2.0-24944519879&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-24944519879&partnerID=MN8TOARS
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
The monoclonal antibody GRC1 was obtained by immunizing BALB/c mice with human cornea. Screening was performed by indirect immunofluorescence in cryostatic sections of several tissues: cornea, skin, placenta, hyaline cartilage, blood vessels, and ner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0dc3772d04b98207d7b05417be4c42dc
http://www.scopus.com/inward/record.url?eid=2-s2.0-0025037830&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0025037830&partnerID=MN8TOARS
Publikováno v:
ResearcherID
Scopus-Elsevier
Digital.CSIC. Repositorio Institucional del CSIC
instname
Europe PubMed Central
Scopus-Elsevier
Digital.CSIC. Repositorio Institucional del CSIC
instname
Europe PubMed Central
Objective. To assess the possible association between PTPN22 1858C→T polymorphism and susceptibility to giant cell arteritis (GCA) and to determine if this polymorphism is implicated in the clinical expression of this vasculitis. Methods. Ninety-si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::23f3516e9722213a0fb7dc547ec3fb9d
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000231103100016&KeyUID=WOS:000231103100016
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000231103100016&KeyUID=WOS:000231103100016